Regulator approves first injectable treatment for prevention of HIV

Cabotegravir has been approved as pre-exposure prophylaxis in the UK in both tablet and injectable form.
injection being held above skin
The cabotegravir long-acting injection is administered six times per year

Shutterstock.com

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved cabotegravir, the first long-acting injection treatment for prevention of HIV-1 infection in the UK.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated